IBD Live Q&A Recap and Stock Lists for Thursday, Dec. 4, 2025

IBD Live returned with a focused Q&A and refreshed stock lists for Thursday, Dec. 4, 2025. The session highlights IBD’s Ready List—stocks that meet the publication’s combined technical and fundamental screening criteria—alongside supplemental lists and practical guidance designed to shorten the learning curve for new and experienced investors.

The Q&A recap compiles frequently asked questions, direct answers from hosts and analysts, and curated links to research tools. Participants can review how the Ready List is constructed, which factors define a qualifying base, and how volume, relative strength, and earnings trends factor into IBD’s selection process. The recap also outlines how to integrate these screened names into personal watchlists, set entry and stop levels, and prioritize setups for swing trading or longer-term investing.

In addition to the Ready List, the update points to sector-specific lists and momentum screens that surface high-conviction trading ideas. Each list is intended to be a starting point: users are encouraged to perform their own due diligence, checking earnings quality, revenue growth, and forward guidance, as well as chart patterns that indicate a reliable breakout or consolidation.

For investors still learning the IBD methodology, the session provides a concise FAQ and links to primer resources covering CAN SLIM principles, key technical indicators, and how to interpret IBD ratings. Veteran traders will find trade-management tips and examples of how to scale positions and manage risk when volatility picks up.

The recap also touches on broader market context for Dec. 4, 2025, noting sector leadership, recent macro headlines that may influence short-term momentum, and how to use the lists to build diversified watchlists. Practical takeaways include setting alerts on high-RS names, confirming base breakouts with volume, and cross-checking fundamental strength before initiating trades.

Whether you’re using the Ready List for idea generation or following sector screens for active setups, the IBD Live Q&A recap consolidates the day’s guidance and tools to help investors act with more confidence. For complete details, users should consult the full IBD Live notes and linked research resources.